Update metadata with huggingface_hub

README.md

@@ -1,6 +1,66 @@
- ---
-quantized_by: bartowski
+---
+base_model: Writer/Palmyra-Med-70B-32K
+language:
+- en
+license: other
+license_name: writer-open-model-license
+license_link: https://writer.com/legal/open-model-license/
 pipeline_tag: text-generation
+tags:
+- instruct
+- finetune
+- DPO
+- distillation
+- heathcare
+- medical
+- clinical
+- med
+- lifescience
+- Pharmaceutical
+- Pharma
+- Enterprise LLM
+- Enterprise
+- Enterprise ready
+quantized_by: bartowski
+extra_gated_prompt: By clicking "Agree", you agree to the [License Agreement](https://writer.com/legal/open-model-license/)
+  and acknowledge Writer's [Privacy Policy](https://writer.com/legal/acceptable-use/).
+extra_gated_fields:
+  Name: text
+  Email: text
+  Organization or Affiliation: text
+  Receive email updates and promotions on Writer products, services, and research?:
+    type: select
+    options:
+    - 'Yes'
+    - 'No'
+  I acknowledge that this model is for non-commercial use only unless I acquire a separate license from Writer: checkbox
+widget:
+- example_title: Palmyra-Med-70B-32k
+  messages:
+  - role: system
+    content: You are a highly knowledgeable and experienced expert in the healthcare
+      and biomedical field, possessing extensive medical knowledge and practical expertise.
+  - role: user
+    content: Does danzhi Xiaoyao San ameliorate depressive-like behavior by shifting
+      toward serotonin via the downregulation of hippocampal indoleamine 2,3-dioxygenase?
+  output:
+    text: Danzhi Xiaoyao San (DXS) exhibited significant antidepressant-like effects
+      in rats subjected to chronic unpredictable mild stress (CUMS), a commonly used
+      model for inducing depressive-like behavior. The administration of DXS led to
+      a notable reduction in the activity of indoleamine 2,3-dioxygenase (IDO) in
+      the hippocampus. This reduction in IDO activity is crucial because IDO is an
+      enzyme that catalyzes the degradation of tryptophan into kynurenine (Kyn), thereby
+      diverting tryptophan away from the serotonin (5-HT) synthesis pathway. By downregulating
+      IDO, DXS effectively shifts the balance of tryptophan metabolism towards increased
+      serotonin production, thereby enhancing the availability of serotonin. This
+      shift in the Kyn/5-HT pathway favoring serotonin is likely a key mechanism underlying
+      the antidepressant effects observed with DXS treatment. Enhanced serotonin levels
+      in the hippocampus are associated with improved mood and reduction of depressive
+      symptoms, suggesting that DXS could be a promising therapeutic agent for managing
+      depression.
+model-index:
+- name: Palmyra-Med-70B-32k
+  results: []
 ---
 
 ## Llamacpp imatrix Quantizations of Palmyra-Med-70B-32K